Clinical trial Recruiting at 1 site Observational Ages 18 to 70

Validating an Arabic version of a quality of life questionnaire for diabetic neuropathy patients

Official title: Neuropathy and Foot Ulcer_ Specific Quality of Life Instrument (Neuro QOL) Arabic Version: Cross-cultural Adaptation, Validity, and Reliability for Patients With Type 2 Diabetes

Run by Cairo University · NCT06483620 · Data updated 2026-11-12

This study is trying to create and test an Arabic version of a quality of life questionnaire for Arabic-speaking patients with diabetic neuropathy to make sure it works well for them.

More Diabetic Peripheral Neuropathy trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment290 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Giza Governorate)
StatusRecruiting
StartedFebruary 13, 2025
Main results expectedDecember 20, 2025
Study endsJanuary 25, 2026
Registry record updatedOctober 3, 2025
Trial IDNCT06483620 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are Arabic-speaking adults aged 18-70 with a diagnosis of type 2 diabetes and no other neurological conditions.

Probably not a fit

Patients with congenital deformities, other neurological diagnoses, or significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to translate, culturally adapt, and validate the Neuro QOL questionnaire for Arabic-speaking diabetic patients suffering from peripheral neuropathy. It involves a cross-cultural validation process to ensure that the Arabic version maintains the reliability and validity of the original instrument. The study will recruit 290 participants aged 18-70 years from outpatient clinics, focusing on those with type 2 diabetes. Expert panels will assess the face and content validity of the translated questionnaire.

Why it matters

Potential benefit: If successful, this study could provide a reliable tool for assessing the quality of life in Arabic-speaking diabetic patients, leading to better-targeted treatments.

How similar studies have gone: While this specific adaptation is novel, similar studies have successfully validated quality of life instruments in other languages and cultures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Arabic is their first language The absence of any other neurological diagnosis affecting the sensory and motor system, such as stroke or multiple sclerosis
* Age ranges between 18 and 70 years,
* History of DM diagnosed by a physician and confirmed by either hemoglobin A1c ≥6.5% or the use of hypoglycemic agents.

Exclusion Criteria:

* A hospital inpatient
* Had pre-existing comorbidities such as cancer, shingles or other neuropathic pain entity that predated diabetes or can mimic or cause a neuropathic pain that is not arising as a result of diabetes.
* Pregnant patients as diabetes may be of gestational type
* Had recently experienced physical trauma that may have contributed to neuropathic pain had trauma or dermatological diseases of the skin as this could affect skin sensitivity (e.g. wounds, psoriasis and eczema).

Where it's running

  • Faculty of Physical Therapy, Cairo University
    Cairo, Giza Governorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Engy BadrEldin S Moustafa, PhD — Faculty of Physical Therapy, Cairo University, Egypt
  • Study coordinator: Engy BadrEldin S Moustafa, PhD
  • Email: engybm.saleh@cu.edu.eg
  • Phone: 00201099445112

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.